Vertebral osteomyelitis after spine instrumentation surgery: risk factors and management

J Hosp Infect. 2023 Oct:140:102-109. doi: 10.1016/j.jhin.2023.07.008. Epub 2023 Jul 22.

Abstract

Background: Vertebral osteomyelitis after spine instrumentation surgery (pVOM) is a rare complication. Most cases of infection occur early after surgery that involve skin and soft tissue and can be managed with debridement, antibiotics, and implant retention (DAIR).

Aim: To identify pVOM risk factors and evaluate management strategies.

Methods: From a multicentre cohort of deep infection after spine instrumentation (IASI) cases (2010-2016), pVOM cases were compared with those without vertebral involvement. Early and late infections were defined (<60 days and >60 days after surgery, respectively). Multivariate analysis was used to explore risk factors.

Findings: Among 410 IASI cases, 19 (4.6%) presented with pVOM, ranging from 2% (7/347) in early to 19.1% (12/63) in late IASIs. After multivariate analysis, age (adjusted odds ratio (aOR): 1.10; 95% confidence interval (CI): 1.03-1.18), interbody fusion (aOR: 6.96; 95% CI: 2-24.18) and coagulase-negative staphylococci (CoNS) infection (aOR: 3.83; 95% CI: 1.01-14.53) remained independent risk factors for pVOM. Cases with pVOM had worse prognoses than those without (failure rate; 26.3% vs 10.8%; P = 0.038). Material removal was the preferred strategy (57.9%), mainly in early cases, without better outcomes (failure rate; 33.3% vs 50% compared with DAIR). Late cases managed with removal had greater success compared with DAIR (failure rate; 0% vs 40%; P = 0.067).

Conclusion: Risk factors for pVOM are old age, use of interbody fusion devices and CoNS aetiology. Although the diagnosis leads to a worse prognosis, material withdrawn should be reserved for late cases or when spinal fusion is achieved.

Keywords: Bone and joint infections; Device-related infections; Infection after spine instrumentation; Orthopaedic surgery; Post-surgical vertebral osteomyelitis.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Debridement
  • Humans
  • Osteomyelitis* / drug therapy
  • Osteomyelitis* / therapy
  • Prognosis
  • Prosthesis-Related Infections* / drug therapy
  • Retrospective Studies
  • Risk Factors
  • Spine / surgery
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents